First AD

Second AD

Emerging role of doublet triplet therapies in R/R CLL: Expert Perspectives

Video content above is prompted by the following:

How do you weigh the potential benefit of a more aggressive 1L treatment against limiting available treatment options in later lines of therapy?

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Optimizing R/R CLL Treatment: Therapy Sequencing and Supportive Care Strategies

Panelists discuss how they balance the potential benefits of aggressive first-line treatment in chronic lymphocytic leukemia against the importance of preserving effective options for subsequent lines of therapy, considering factors such as patient prognosis, treatment goals, and the evolving landscape of available therapies.

The Current Treatment Landscape for R/R CLL